Outcomes Associated With Potassium Abnormalities in CKD: It Is Time to Move to Clinical Trials

Affiliations

¹ Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center and Nephrology Section, Memphis VA Medical Center, Memphis, Tennessee. Electronic address: ckovesdy@uthsc.edu.

Editorial

Csaba P Kovesdy. Am J Kidney Dis. 2023 Sep.

. 2023 Sep;82(3):251-253.

doi: 10.1053/j.ajkd.2023.05.002. Epub 2023 Jun 27.

¹ Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center and Nephrology Section, Memphis VA Medical Center, Memphis, Tennessee. Electronic address: ckovesdy@uthsc.edu.

No abstract available

Comment on

Serum Potassium and Risk of Death or Kidney Replacement Therapy in Older People With CKD Stages 4-5: Eight-Year Follow-up.
de Rooij ENM, de Fijter JW, Le Cessie S, Hoorn EJ, Jager KJ, Chesnaye NC, Evans M, Windahl K, Caskey FJ, Torino C, Szymczak M, Drechsler C, Wanner C, Dekker FW, Hoogeveen EK; EQUAL Study Investigators. de Rooij ENM, et al. Am J Kidney Dis. 2023 Sep;82(3):257-266.e1. doi: 10.1053/j.ajkd.2023.03.008. Epub 2023 May 12. Am J Kidney Dis. 2023. PMID: 37182596